Published in Toxins (Basel) on March 09, 2017
A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis (2013) 3.75
Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med (1998) 3.42
Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J Clin Microbiol (2011) 2.59
Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys (1995) 2.57
Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J Clin Microbiol (2012) 2.28
The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal Biochem (2006) 1.63
Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol (2010) 1.57
Genetic interrelationships of proteolytic Clostridium botulinum types A, B, and F and other members of the Clostridium botulinum complex as revealed by small-subunit rRNA gene sequences. Antonie Van Leeuwenhoek (1994) 1.50
From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal Chem (2005) 1.48
Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods. J Assoc Off Anal Chem (1977) 1.44
Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. PLoS One (2009) 1.35
Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLoS One (2010) 1.28
Evaluation of the Bruker Biotyper and VITEK MS MALDI-TOF MS systems for the identification of unusual and/or difficult-to-identify microorganisms isolated from clinical specimens. Eur J Clin Microbiol Infect Dis (2014) 1.19
Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Anal Chem (2005) 1.17
Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem (1996) 1.15
Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens. Am J Clin Pathol (1976) 0.98
Quantitative matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid resistance detection. J Clin Microbiol (2014) 0.94
Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochem (2011) 0.85
Confirmation of botulism in birds and cattle by the mouse bioassay and Endopep-MS. J Med Microbiol (2011) 0.84
Detection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS. J Agric Food Chem (2015) 0.83
Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization. Diagn Microbiol Infect Dis (1985) 0.78